NeoPhore Scientific Founders Publish Breakthrough Immuno-oncology Discoveries in Nature

Collaboration by company and founders will offer further insights into DNA repair and cancer immunity

29th November 2017, Cambridge, UK – The internationally recognised scientific journal Nature has published innovative cancer research by NeoPhore Ltd founders Professor Alberto Bardelli and Giovanni Germano PhD at the University of Torino, revealing findings that further establish and validate NeoPhore’s distinctive therapeutic concept of creating first-in-class small molecule drugs to stimulate the immune system and attack cancer in a fundamental and disruptive way. The paper is entitled “Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth” and can be found here:

To continue reading the press release please click here

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...